Kirkland & Ellis Announces New Partners
Kirkland & Ellis LLP is pleased to announce that 151 attorneys have been promoted to partner effective today.
Austin
Name |
Practice Area |
Emily Lichtenheld |
M&A/Private Equity |
Brice Lipman |
M&A/Private Equity |
Patrick V. Salvo |
M&A/Private Equity |
Kate Rainey Willson |
M&A/Private Equity |
Bay Area
Name |
Practice Area |
James Brownstein |
M&A/Private Equity |
James Devereux |
Investment Funds |
Jana Glock |
M&A/Private Equity |
Amber Harezlak |
Technology & IP Transactions |
Eva Mak |
M&A/Private Equity |
Rachel O’Brien |
Investment Funds |
Andrew D. Walker |
M&A/Private Equity |
Emma Whenham |
Investment Funds |
Boston
Name |
Practice Area |
Daniel S. Connelly |
M&A/Private Equity |
Benjamin J. Dionne |
M&A/Private Equity |
Kyle E. Garry |
Investment Funds |
Anne Marie Martin |
Investment Funds |
Julia S. Sternman |
Investment Funds |
Daniel W. Vaczy |
M&A/Private Equity |
Chicago
Name |
Practice Area |
Jonathan N. Adair |
Litigation |
Valentine Bleicher |
M&A/Private Equity |
Nick Carreri |
Investment Funds |
Michael J. Conroy |
Tax |
Matthew C. Darch |
Technology & IP Transactions |
Jonathan A. Dhanawade |
M&A/Private Equity |
Jaimie Fedell |
Restructuring |
Melesa A. Freerks |
M&A/Private Equity |
Miles Johnson |
Tax |
Kyle M. Kantarek |
IP Litigation |
Katie R. Lencioni |
Litigation |
Kyle P. McHugh |
M&A/Private Equity |
Kristen E. Molloy |
M&A/Private Equity |
Noah M. Mullin |
Investment Funds |
Kat Murphy |
M&A/Private Equity |
Brett R. Nelson |
M&A/Private Equity |
Kevin Pavloski |
Investment Funds |
Tim Pickert |
Litigation |
Jesse Lee Reising |
Litigation |
Jeremy D. Roux |
IP Litigation |
Daniel S. Schwimmer |
Debt Finance |
Jeffrey J. Seroogy |
Technology & IP Transactions |
Zharna Shah |
Litigation |
Brandon D. Stone |
Litigation |
Sam Stucker |
M&A/Private Equity |
Jenna M. Stupar |
Litigation |
Frances G. Tompson |
Executive Compensation |
Joel E. Weinberger |
Asset Finance & Securitization |
Matthew Whited |
M&A/Private Equity |
Sam Zeller |
M&A/Private Equity |
Dallas
Name |
Practice Area |
Camille Bacon-Schulte |
Real Estate |
Ben A. Barnes |
Litigation |
Ben Hardison |
M&A/Private Equity |
Shan A. Khan |
Debt Finance |
Danny Nappier |
M&A/Private Equity |
Jack R. Shirley |
M&A/Private Equity |
Rami Totari |
M&A/Private Equity |
Hong Kong
Name |
Practice Area |
Ethan Y. Chen |
Capital Markets |
Nicholas Liew |
Investment Funds |
Houston
Name |
Practice Area |
Alexandra Caritis |
Litigation |
Tabitha De Paulo |
Litigation |
James Dolphin |
Environmental Transactions |
Brandon C. Elliott |
Debt Finance |
Jennifer R. Gasser |
M&A/Private Equity |
Daniel P. Gross |
IP Litigation |
Mark Holden |
Litigation |
Lindsey M. Jaquillard |
M&A/Private Equity |
Atma Kabad |
Capital Markets |
Paul R. Knowlton |
M&A/Private Equity |
Hamish R. McCormack |
Debt Finance |
Stephen S. Noh |
M&A/Private Equity |
Ty'Meka M. Reeves-Sobers |
Environmental Transactions |
Samara Sanderson |
Investment Funds |
Randy S. Santa Ana |
M&A/Private Equity |
Rebekah McEntire |
Litigation |
Joshua Teahen |
M&A/Private Equity |
Joe Tobias |
Tax |
Matthew D. Turner |
Capital Markets |
London
Name |
Practice Area |
Samita T. Ali-Khan |
Capital Markets |
Stefan Arnold-Soulby |
Debt Finance |
Kanesh Balasubramaniam |
Debt Finance |
Henry Birch |
M&A/Private Equity |
Nick-Raj Birdi |
M&A/Private Equity |
Ian Clarke |
Restructuring |
James Collins |
Debt Finance |
Hannah Crawford |
Restructuring |
Agne (AJ) Eriksson |
Investment Funds |
Philipp Gnatzy |
Antitrust & Competition |
James Hunn |
M&A/Private Equity |
Zach Milloy |
Financial Services Regulatory |
Cillian Moynihan |
M&A/Private Equity |
John Patten |
Technology & IP Transactions |
Peter Pereira | IP Litigation |
Katerina Syomina | Investment Funds |
Athina Van Melkebeke | Antitrust & Competition |
Art Ward |
Tax |
Kai Zeng |
Restructuring |
Los Angeles
Name |
Practice Area |
Marcy Blattner |
Litigation |
Saghar Esfandiarifard |
Litigation |
Matthew Gamsin |
Litigation |
Paul Kang, Jr. |
Debt Finance |
Michael Lee |
Investment Funds |
Matthew N. Leist |
Debt Finance |
J. Patrick Park |
IP Litigation |
Lindsey Y. Shi |
IP Litigation |
Brook Sutton |
Investment Funds |
Christopher A. Urruela Stauss |
Investment Funds |
Munich
Name |
Practice Area |
Dr. Sebastian Häfele |
M&A/Private Equity |
Dr. David Huthmacher |
M&A/Private Equity |
New York
Name |
Practice Area |
Gilad Bendheim |
Litigation |
East Goitom Berhane |
Debt Finance |
Lindsay M. Borgeson |
M&A/Private Equity - Healthcare |
Jonathan D. Brit |
IP Litigation |
Christopher Burwell |
M&A/Private Equity |
Daniel R. Cellucci |
Litigation |
Sarah E. Curry |
Capital Markets |
Alexander C. Cushman |
Debt Finance |
James B. Dickson |
Debt Finance |
Jake A. Ebers |
Executive Compensation |
Allison Gallagher |
Capital Markets |
Jeffrey R. Goldfine |
Litigation |
Christopher Ilardi |
IP Litigation |
Jaye Kasper |
M&A/Private Equity |
April Larkin |
M&A/Private Equity |
Eduardo M. Leal |
M&A/Private Equity |
Kurt Lyn |
M&A/Private Equity |
Mark C. McLennan |
IP Litigation |
Kevin M. Neylan, Jr. |
Litigation |
Steven Ort |
Tax |
Eric L. Perelman |
Investment Funds |
Evangelia Podaras |
Employment & Labor |
Noah Qiao |
Investment Funds |
Damien J. Rose |
Tax |
Tobias Dylan Schad |
M&A/Private Equity |
Sarah J. Schultes |
Litigation |
Adarsh Varghese |
M&A/Private Equity |
Lanre Williams |
Real Estate |
Matthew Wood |
Executive Compensation |
Jabir Yusoff |
Executive Compensation |
Paris
Name |
Practice Area |
Sonia Bouaffassa |
Tax |
Emmanuel Enrici |
M&A/Private Equity |
Louis Gosset |
M&A/Private Equity |
Washington D.C.
Name |
Practice Area |
Lucille Hague |
International Trade & National Security |
Andrew C. Lawrence |
Appellate |
Emily Merki Long |
Litigation |
T.J. McCarrick |
Litigation |
Samantha R. Morelli |
Antitrust & Competition |
K. Ross Powell |
Litigation |
Joseph C. Schroeder |
Litigation |
Carrie Schroll |
International Trade & National Security |
C. Alex Shank |
IP Litigation |
Sarah Smith |
Litigation |
McClain Thompson |
Litigation |
Note: For certain partners, admission will take effect when any necessary regulatory requirements have been satisfied.